b7e0ca6ad2da63cce2ee645b4a9627fd
Xpert®CT/NG Assay
CEPHEID AB·III·Ecuador ARCSA·Registered March 18, 2016
Device classification
- Risk class
- III
- Product type
- In Vitro Diagnostic
- Brand name
- CEPHEID
- Commercial name
- IVD Reagents/Kits, Molecular Assay, Infection, Bacteria, Chlamydia trachomatis/Neisseria gonorrhoeae, DNA
- Sterilization method
- BIOLOGIA MOLECULAR PCR
Registration information
- Analysis ID
- b7e0ca6ad2da63cce2ee645b4a9627fd
- Registration date
- March 18, 2016
- Expiration date
- March 18, 2026
- Creation date
- February 17, 2021
Manufacturer
- Name
- CEPHEID AB
- City
- LONDON
- Country
- SWEDEN
- Address
- RONTGENVAGEN 5, SE-171 54
Product owner
- Name
- CEPHEID AB
- Country
- SWEDEN
Authorized representative
- Address
- TODOS LOS SANTOS # 201 AND AV. JORGE PEREZ CONCHA
- Phone
- 2610680
Product use
FOR THE DIAGNOSIS OF UROGENITAL DISEASE DUE TO CHLAMYDIA AND GONORRHEA
About this record
Access comprehensive regulatory information for Xpert®CT/NG Assay in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID b7e0ca6ad2da63cce2ee645b4a9627fd and manufactured by CEPHEID AB. The device was registered on March 18, 2016.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.